Moderna stock jumps over 11% on coronavirus vaccine trial results
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid .
Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Spartan Energy surges 29% after inking $2.9 billion 'blank check' merger with Tesla competitor Fisker Inc. (SPAQ) | Markets InsiderSpartan Energy surged as much as 29% on Monday after it inked a merger agreement with Fisker Inc., an electric vehicle automotive company. Spart...
Read more »
Moderna's stock shoots up as it is set to join the Nasdaq 100Shares of Moderna Inc. undefined shot up 9.3% in morning trading Monday, after Nasdaq said it was adding the drugmaker to the Nasdaq 100 Index undefined,...
Read more »
Moderna expects to start late-stage COVID-19 vaccine trial on July 27Moderna Inc said on Tuesday it plans to start a late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov.
Read more »
Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' statusThe U.S.-listed shares of the German firm climbed about 10%, while Pfizer&39;s stock rose about 2% before the bell. The companies are in a global race with Moderna Inc , AstraZeneca Plc and others to develop a vaccine for COVID-19, the respiratory illness caused by the new coronavirus, which has claimed
Read more »
Stocks making the biggest moves after hours: Tesla, BioNTech, Moderna and moreSee which stocks are posting big moves after the bell.
Read more »
Moderna says its coronavirus vaccine trial produced 'robust' immune response in all patientsModerna's potential vaccine to prevent Covid-19 produced neutralizing antibodies in all 45 patients in its early stage human trial, according to newly released data.
Read more »